Fresenius SE & Co. KGaA Stock Forecast for 2023 - 2025 - 2030

Updated on 03/27/2024

Stock Rating
18
Price Target
35.00€
Consensus
Outperform
Upside
37.42%
Analysts
6
Stock Rating
18
Upside
37.42%
Analysts
6
Price Target
35.00€

Fresenius SE & Co. KGaA Stock Forecast and Price Target

The average price target for Fresenius SE & Co. KGaA's stock of 35.00€ recently provided by six leading analysts would represent a 37.42% upside from its last closing price if reached. This potential increase is based on a high estimate of 70.00€ and a low estimate of 28.00€. If you are looking to invest in the stock, it's important to research and compare different companies.

35.00€

37.42% Upside

Outperform
Outperform

Fresenius SE & Co. KGaA Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Fresenius SE & Co. KGaA's Price has seen a drop from 39.45€ to 0.00€ – a 100.00% decrease. In the next year, analysts predict that Fair Value will jump to 37.73€ – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.

2024 Fair Value Forecast
37.73€
2025 Fair Value Forecast
43.98€
2026 Fair Value Forecast
44.47€
2027 Fair Value Forecast
48.88€
2028 Fair Value Forecast
55.98€
2029 Fair Value Forecast
51.73€
2030 Fair Value Forecast
49.40€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LLY Stock Forecast Eli Lilly and Outperform 16
$734.37 Buy/Sell $636.99 10.71%
NOVO B Stock Forecast Novo Nordisk A/S Outperform 12
kr895.10 Buy/Sell kr696.07 6.13%
MRK Stock Forecast Merck Outperform 2
$122.77 Buy/Sell $130.51 9.96%
NESN Stock Forecast Nestlé Outperform 11
CHF93.99 Buy/Sell CHF115.58 16.50%
ROG Stock Forecast Roche Holding Hold 16
CHF242.00 Buy/Sell CHF307.83 11.57%

Fresenius SE & Co. KGaA Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Fresenius SE & Co. KGaA's Revenue has grown, moving from 36.28€B to 40.84€B – an increase of 12.58%. According to 4 major analysts, Fresenius SE & Co. KGaA's Revenue will fall by 29.35% in the next year, reaching 28.85€B. Professionals believe that By 2030, Fresenius SE & Co. KGaA's Revenue will fall to 28.43€B– a 30.38% decrease from its current value.

2024 Rev Forecast
28.85€B
2025 Rev Forecast
30.25€B
2026 Rev Forecast
26.35€B
2027 Rev Forecast
27.72€B
2028 Rev Forecast
29.01€B
2029 Rev Forecast
29.53€B
2030 Rev Forecast
28.43€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ABT Stock Forecast Abbott Laboratories Outperform 9
$120.19 Buy/Sell $118.92 4.83%
AZN Stock Forecast AstraZeneca PLC Outperform 17
£104.50 Buy/Sell £165.99 53.79%
NOVN Stock Forecast Novartis Outperform 10
CHF88.80 Buy/Sell CHF105.00 23.95%

Fresenius SE & Co. KGaA Dividend per Share Forecast for 2023 - 2025 - 2030

In the last two years, Fresenius SE & Co. KGaA's Dividend per Share has seen an increase, rising from 0.88€ to 0.92€. This represents a growth of 4.55%. Analysts predict that Fresenius SE & Co. KGaA's Dividend per Share will increase in the upcoming year, reaching 1.02€. This would represent an increase of 10.87%. Over the next seven years, experts predict that Fresenius SE & Co. KGaA's Dividend per Share will grow at a rate of 47.83%.

2024 DPS Forecast
1.02€
2025 DPS Forecast
1.13€
2026 DPS Forecast
1.23€
2027 DPS Forecast
1.23€
2028 DPS Forecast
1.23€
2029 DPS Forecast
1.29€
2030 DPS Forecast
1.36€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PFE Stock Forecast Pfizer Outperform 2
$28.37 Buy/Sell $32.87 10.82%
SAN Stock Forecast Sanofi Outperform 16
88.32€ Buy/Sell 102.80€ 21.15%
GSK Stock Forecast GSK Outperform 12
£16.75 Buy/Sell £17.30 11.04%

Fresenius SE & Co. KGaA Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
2.41€B
2025 FCF Forecast
2.45€B
2026 FCF Forecast
2.65€B
2027 FCF Forecast
2.80€B
2028 FCF Forecast
2.66€B
2029 FCF Forecast
2.59€B
2030 FCF Forecast
2.62€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BDX Stock Forecast Becton Dickinson and Co Outperform 9
$239.50 Buy/Sell $284.47 16.91%
SUNPHARMA Stock Forecast Sun Pharmaceutical Industries Outperform 8
Rp1.59k Buy/Sell Rp1.52k -1.42%
BN Stock Forecast Danone Outperform 11
58.97€ Buy/Sell 55.47€ 8.53%

Fresenius SE & Co. KGaA EBITDA Forecast for 2023 - 2025 - 2030

In the last two years, Fresenius SE & Co. KGaA's EBITDA has decreased from 6.17€B to 5.07€B – a 17.82% drop. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach 5.39€B – an increase of 6.26%. Over the next seven years, experts anticipate that EBITDA growth for Fresenius SE & Co. KGaA will be 0.01%.

2024 EBITDA Forecast
5.39€B
2025 EBITDA Forecast
5.87€B
2026 EBITDA Forecast
4.77€B
2027 EBITDA Forecast
5.09€B
2028 EBITDA Forecast
4.88€B
2029 EBITDA Forecast
5.22€B
2030 EBITDA Forecast
5.07€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
4543 Stock Forecast Terumo Outperform 18
¥5.63k Buy/Sell ¥4.97k -9.46%
BAX Stock Forecast Baxter International Inc Outperform 17
$43.48 Buy/Sell $44.86 3.50%
500124 Stock Forecast Dr. Reddy's Laboratories Hold 18
Rp6.38k Buy/Sell Rp5.67k -6.20%

Fresenius SE & Co. KGaA EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Fresenius SE & Co. KGaA's EBIT has decreased by 24.68%, going from 4.47€B to 3.37€B. 3 analysts predict Fresenius SE & Co. KGaA's EBIT will decrease by 6.57% in the next year, reaching 3.15€B. For the next seven years, the forecast is for EBIT to grow by 28.85%.

2024 EBIT Forecast
3.15€B
2025 EBIT Forecast
3.57€B
2026 EBIT Forecast
2.97€B
2027 EBIT Forecast
3.21€B
2028 EBIT Forecast
5.52€B
2029 EBIT Forecast
4.98€B
2030 EBIT Forecast
4.34€B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
HIK Stock Forecast Hikma Pharmaceuticals PLC Outperform 18
£19.10 Buy/Sell £28.11 55.34%
002422 Stock Forecast Sichuan Kelun Pharmaceutical Outperform 16
¥27.85 Buy/Sell ¥37.90 43.63%
GRF Stock Forecast Grifols Outperform 18
8.48€ Buy/Sell 18.48€ 116.98%

Fresenius SE & Co. KGaA EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Fresenius SE & Co. KGaA's EPS has seen a drop from 3.22€ to 0.00€ – a 100.00% decrease. In the next year, analysts predict that EPS will jump to 3.08€ – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.

2024 EPS Forecast
3.08€
2025 EPS Forecast
3.59€
2026 EPS Forecast
3.63€
2027 EPS Forecast
3.99€
2028 EPS Forecast
4.57€
2029 EPS Forecast
4.22€
2030 EPS Forecast
4.03€
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
PRGO Stock Forecast Perrigo Co PLC Outperform 16
$30.59 Buy/Sell $44.75 27.49%
HAE Stock Forecast Haemonetics Outperform 16
$78.36 Buy/Sell $70.17 38.46%
BHC Stock Forecast Bausch Health Companies Hold 15
$9.12 Buy/Sell $9.50 -1.32%